by Memorial Sloan Kettering Cancer Center Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes the prostate gland to shrink by 90%....
Tag: <span>hormone therapy</span>
Post
Prolonged use of hormone therapy may minimize muscle loss associated with aging
by The North American Menopause Society Skeletal muscle mass and strength are critical in helping prevent falls, fractures, and disability. Yet, they continue to decline during the menopause transition. A new study showed that the prolonged use (defined as ≥13 mo) of hormone therapy (HT) was associated with higher muscle mass and less chance of...
Post
How does hormone therapy affect heart health in transgender people?
Cardiovascular health in transgender people requires a multifaceted approach to care, according to a new report that looked at a range of issues in how hormone therapy affects heart health. The study, published Monday in the American Heart Association journal Hypertension, set out to create a guidepost for future medical care by examining past research...
Post
Why do estradiol levels vary among women using hormone therapy?
New study based on ELITE data identifies multiple determinants affecting estradiol levels and a woman’s protection against atherosclerosis THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS) CLEVELAND, Ohio (September 24, 2019)–The benefits of hormone therapy (HT) on atherosclerosis relates to achieved estradiol levels among those women who initiate HT early in postmenopause. Despite the use of hormones,...
Post
First PI3K inhibitor approved for metastatic, advanced breast cancer
(HealthDay)—Piqray (alpelisib) tablets were approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer in combination with fulvestrant, the U.S. Food and Drug Administration announced Friday. The tablets were approved for use in men and postmenopausal women whose disease progressed after treatment with an endocrine-based regimen. The drug was also approved in combination with a companion diagnostic test, the...
Post
Hormone therapy can make prostate cancer worse, study finds
CEDARS-SINAI MEDICAL CENTER LOS ANGELES (Sept. 4, 2018) — Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer...
Post
Scientists identify biomarkers to guide hormone therapy for prostate cancer
A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy, according to a study led by scientists at UC San Francisco and the University of Michigan. While hormone therapy has been used successfully to treat many prostate cancer patients, until now, researchers have been...